Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667385 | SCV000791820 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger) | 2017-05-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001091386 | SCV001247405 | pathogenic | not provided | 2019-03-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003767954 | SCV004671685 | pathogenic | Zellweger spectrum disorders | 2024-01-24 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the PEX1 mRNA. The next in-frame methionine is located at codon 209. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individuals with Zellweger syndrome (PMID: 21031596, 28468868). ClinVar contains an entry for this variant (Variation ID: 552166). For these reasons, this variant has been classified as Pathogenic. |